Debt to Equity Ratio Chart

View Debt to Equity Ratio for TNDM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 5.670
March 31, 2026 5.549
December 31, 2025 2.896
September 30, 2025 3.379
June 30, 2025 3.369
March 31, 2025 3.176
December 31, 2024 1.80
September 30, 2024 2.002
June 30, 2024 2.04
March 31, 2024 1.965
December 31, 2023 1.325
September 30, 2023 1.332
June 30, 2023 1.277
March 31, 2023 1.241
December 31, 2022 0.9544
September 30, 2022 1.000
June 30, 2022 0.9388
March 31, 2022 0.9584
December 31, 2021 0.7265
September 30, 2021 0.8109
June 30, 2021 0.9166
March 31, 2021 1.017
December 31, 2020 0.6233
September 30, 2020 0.6933
June 30, 2020 0.8303
Date Value
March 31, 2020 0.1345
December 31, 2019 0.1045
September 30, 2019 0.127
June 30, 2019 0.151
March 31, 2019 0.1189
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 2.965
March 31, 2018 6.449
December 31, 2017 -2.626
September 30, 2017 -2.704
June 30, 2017 -4.085
March 31, 2017 -39.49
December 31, 2016 -13.32
September 30, 2016 8.598
June 30, 2016 1.384
March 31, 2016 0.96
December 31, 2015 0.4675
September 30, 2015 0.4141
June 30, 2015 0.3359
March 31, 2015 0.2881
December 31, 2014 0.5395
September 30, 2014 0.4359
June 30, 2014 0.3518
March 31, 2014 0.3027

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
DexCom, Inc. 0.5335
Modular Medical, Inc. 0.0258
Senseonics Holdings, Inc. 0.6956
NeuroPace, Inc. 5.885
Abbott Laboratories 0.638